Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Journal of Psychopharmacology (Oxford, England)|September 27, 2022
The effect of AUT00206, a Kv3 potassium channel modulator, on dopamine synthesis capacity and the reliability of [18F]-FDOPA imaging in schizophreniaIlinca Angelescu, Stephen J Kaar, Tiago Reis Marques, et al.
The Lancet. Psychiatry|September 22, 2018
The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging studySameer Jauhar, Robert McCutcheon, Faith Borgan, et al.
NPJ Schizophrenia|August 28, 2020
Links between central CB1-receptor availability and peripheral endocannabinoids in patients with first episode psychosisAlex M Dickens, Faith Borgan, Heikki Laurikainen, et al.
Molecular Psychiatry|April 17, 2020
GABA-A receptor differences in schizophrenia: a positron emission tomography study using [11C]Ro154513Tiago Reis Marques, Abhishekh H Ashok, Ilinca Angelescu, et al.
Neuroimage|October 9, 2018
Sex difference in brain CB1 receptor availability in manHeikki Laurikainen, Lauri Tuominen, Maria Tikka, et al.
JAMA Network Open|May 22, 2020
Association of Ketamine With Psychiatric Symptoms and Implications for Its Therapeutic Use and for Understanding Schizophrenia: A Systematic Review and Meta-analysisKatherine Beck, Guy Hindley, Faith Borgan, et al.
Translational Psychiatry|May 30, 2023
The relationship between striatal dopamine and anterior cingulate glutamate in first episode psychosis changes with antipsychotic treatmentSameer Jauhar, Robert A McCutcheon, Mattia Veronese, et al.
Frontiers in Psychiatry|August 29, 2022
The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: A 1H-MRS study in first-episode psychosis patientsUzma Zahid, Robert A McCutcheon, Faith Borgan, et al.
Frontiers in Psychiatry|March 18, 2024
Corrigendum: The effect of antipsychotics on glutamate levels in the anterior cingulate cortex and clinical response: a 1H-MRS study in first-episode psychosis patientsUzma Zahid, Robert A McCutcheon, Faith Borgan, et al.
JAMA Psychiatry|July 4, 2019
In Vivo Availability of Cannabinoid 1 Receptor Levels in Patients With First-Episode PsychosisFaith Borgan, Heikki Laurikainen, Mattia Veronese, et al.
Pageof 3